Tricaprilin

Tricaprilin (CAS No.: 538-23-8) is a medium-chain triglyceride primarily used to promote ketone body production, thereby inducing a state of ketosis, which is of significant importance in metabolic research. As an active compound in biomedical research, Tricaprilin has shown considerable potential in the study of neurological disorders, particularly in enhancing brain energy metabolism and stabilizing electrical activity. Although its known primary function is to induce a state of ketosis, Tricaprilin also plays a key role in regulating neuroinflammatory pathways associated with migraine and Alzheimer’s disease. Its biochemical activity can provide the nervous system with a rapidly usable energy source without relying on traditional glucose pathways, thereby altering cellular metabolism. Although specific in vitro data are lacking, studies of Tricaprilin in rodent models have shown that its regulatory effects on key enzymes such as glucose-6-phosphate dehydrogenase and ATP citrate lyase may have profound effects on lipid metabolism. Changes in these enzymes and their selective effects on tumor cells suggest its potential use in future oncology research. Its common applications include exploring its potential research value using cell and animal models in strictly controlled research settings, with specific experimental designs and dosages typically depending on research objectives. Its broad application prospects and good safety profile make it an important tool for studying the complex pathways of neurodegenerative diseases and metabolic dysregulation.